The store will not work correctly when cookies are disabled.
N-(4-(dimethylcarbamoyl)phenyl)-2,4-dihydroxy-N-((1-methyl-1H-pyrazol-3-yl)methyl)benzamide
ID: ALA3733242
PubChem CID: 127024786
Max Phase: Preclinical
Molecular Formula: C21H22N4O4
Molecular Weight: 394.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)C(=O)c1ccc(N(Cc2ccn(C)n2)C(=O)c2ccc(O)cc2O)cc1
Standard InChI: InChI=1S/C21H22N4O4/c1-23(2)20(28)14-4-6-16(7-5-14)25(13-15-10-11-24(3)22-15)21(29)18-9-8-17(26)12-19(18)27/h4-12,26-27H,13H2,1-3H3
Standard InChI Key: XWRKXLAABPAXIJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 2.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6024 2.6977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2003 1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4990 0.7409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8964 -0.7553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1931 -1.5094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1885 -3.0094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8871 -3.7554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5904 -3.0014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -1.5014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8793 -5.2562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5762 -6.0007 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9156 -5.8612 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5700 -7.2007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5399 -5.3957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8525 1.3572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8524 0.2390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.0978 -1.0574 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.6317 -0.7404 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-8.5821 -2.1553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
3 8 1 0
4 9 1 0
9 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
11 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
21 24 1 0
13 25 1 0
25 26 2 0
26 27 1 0
27 28 1 0
28 13 2 0
27 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 394.43 | Molecular Weight (Monoisotopic): 394.1641 | AlogP: 2.38 | #Rotatable Bonds: 5 |
Polar Surface Area: 98.90 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.83 | CX Basic pKa: 1.66 | CX LogP: 1.85 | CX LogD: 1.72 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.69 | Np Likeness Score: -1.43 |
References
1. (2015) Resorcinol n-aryl amide compounds, for use as pyruvate dehydrogenase kinase inhibitors, |